Overview
Overview
NYLI U.S. Large Cap R&D Leaders Index (IQLCRNDT) seeks to provide exposure to highly innovative companies through the selection of equities in the U.S. large cap universe with the highest R&D spending in the past year. Companies with high R&D spending are investing for future growth in their business and may enjoy strong long-term competitive positioning.
Performance
Performance
The performance data quoted above represents past performance. Past performance is not a guarantee of future results. Performance may be lower or higher than performance data quoted. Index performance is for illustrative purposes only and does not represent actual Fund performance. One cannot invest directly in an index. Performance data for the Index assumes reinvestment of dividends and is net of the management fees for the Index's components, as applicable, but it does not reflect management fees, transaction costs or other expenses that you would pay if you invested in the Fund directly. Results prior to an Index component's existence as an ETF are based on its underlying index, which do not reflect underlying management fees.
The constituents of the Russell 1000® Index were used by New York Life Investment Management LLC (NYLIM) as the starting universe for selection of the companies included in the NYLI U.S. Large Cap R&D Leaders Index. FTSE International Limited and its affiliates (“FTSE Russell”) do not in any way create, calculate, maintain, review, sponsor, support, promote or endorse the NYLI U.S. Large Cap R&D Leaders Index or the NYLI U.S. Large Cap R&D Leaders ETF. In no event shall any FTSE Russell party have any liability for any direct, indirect, special, incidental, punitive, consequential (including without limitation lost profits) or any other damages in connection with the constituents of the Russell 1000® Index or the NYLI U.S. Large Cap R&D Leaders Index.